FdaApplication

NDA 204708

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGALDERMA LABORATORIES LP
application_typeNDA
approval_date2013-08-23

Products (1)

ProductActive ingredientStrengthDosage form
MIRVASOBRIMONIDINE TARTRATEEQ 0.33% BASEGEL;TOPICAL

1 product